[{"innerBlocks":[],"name":"core\/freeform","postId":3719,"blockType":{"name":"core\/freeform","keywords":[],"attributes":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"providesContext":[],"usesContext":[],"selectors":[],"supports":{"className":false,"customClassName":false,"reusable":false},"styles":[],"variations":[],"apiVersion":3,"title":"Classic","description":"Use the classic WordPress editor.","category":"text"},"originalContent":"The Trump Administration's emphasis on deregulation suggests there could be changes ahead in the relationship between health information technology vendors and current and prospective customers.

Many IT purchasing decisions have been focused on complying with regulatory programs such as electronic health records meaningful use, MACRA and MIPs, says Christopher McCord, managing director and partner at Healthcare Growth Partners, an HIT investment and merchant bank that publishes an annual study of the status and future of health IT.

Also See:<\/b> Why many group practices are worrying about a MACRA shift<\/a>

Providers have been buying IT tools they needed to comply with regulatory requirements and checking off the boxes as these tools are acquired. But now, some vendors may face shrinking demand for their products.

Vendors whose sales are highly dependent on supporting regulatory mandates could see a downturn in business.

\u201cThe risk for vendors is higher under President Trump because he is moving toward deregulation, and purchasing decisions have been made to satisfy regulatory requirements,\u201d McCord explains.

Also See:<\/b> 11 trends that HIT executives see for EHRs<\/a>

How much regulation remains and how much goes away isn\u2019t yet known, but vendors will need to focus less on technology and more on bringing added value to providers by helping them drive revenue or cut costs, he adds. \u201cVendors have to pivot and build a business case based on strong value propositions to the customers they serve.\u201d

The MACRA and MIPS programs likely won\u2019t be as onerous to providers under the new administration as they have been, but McCord doesn\u2019t believe those programs are going away because of bipartisan support from policymakers.

The full report from Healthcare Growth Partners is available for free here<\/a>.
","saveContent":"The Trump Administration's emphasis on deregulation suggests there could be changes ahead in the relationship between health information technology vendors and current and prospective customers.

Many IT purchasing decisions have been focused on complying with regulatory programs such as electronic health records meaningful use, MACRA and MIPs, says Christopher McCord, managing director and partner at Healthcare Growth Partners, an HIT investment and merchant bank that publishes an annual study of the status and future of health IT.

Also See:<\/b> Why many group practices are worrying about a MACRA shift<\/a>

Providers have been buying IT tools they needed to comply with regulatory requirements and checking off the boxes as these tools are acquired. But now, some vendors may face shrinking demand for their products.

Vendors whose sales are highly dependent on supporting regulatory mandates could see a downturn in business.

\u201cThe risk for vendors is higher under President Trump because he is moving toward deregulation, and purchasing decisions have been made to satisfy regulatory requirements,\u201d McCord explains.

Also See:<\/b> 11 trends that HIT executives see for EHRs<\/a>

How much regulation remains and how much goes away isn\u2019t yet known, but vendors will need to focus less on technology and more on bringing added value to providers by helping them drive revenue or cut costs, he adds. \u201cVendors have to pivot and build a business case based on strong value propositions to the customers they serve.\u201d

The MACRA and MIPS programs likely won\u2019t be as onerous to providers under the new administration as they have been, but McCord doesn\u2019t believe those programs are going away because of bipartisan support from policymakers.

The full report from Healthcare Growth Partners is available for free here<\/a>.
","order":0,"get_parent":{},"attributes":[],"attributesType":{"content":{"type":"string","source":"raw"},"lock":{"type":"object"}},"dynamicContent":""}]

Trump focus on deregulation could lower reporting burdens

More for you